Answers are grounded in this paper and cite their sources.
The resurgence of herbal practices globally underscores a shift toward herbal medicine for the management of neurodegenerative disorder, with concerns about pharmaceutical safety driving this trend.Various synthetic drugs are available in the market aimed for the treatment of neurodegenerative disorder but these drugs come with the lot of side effects which causes the shifting of over 80% population towards the plant based medicine.This research investigates the inhibitory potential of Glycine max (L.) Merr.(Soybean) constituents on NADPH oxidase which plays a key role in neurodegenerative disorder using molecular docking and pharmacokinetic studies.The aim is to contribute to knowledge on the therapeutic applications of soybean compounds targeting oxidative stress.Molecular docking with AutoDock Vina/ CADD labshare and pharmacokinetic predictions using the Swiss ADME web tool were employed to assess the interactions and properties of G. max compounds affecting NADPH oxidase.The study reveals significant interactions between soybean constituents and NADPH oxidase, suggesting potential inhibitory effects.Pharmacokinetic analyses provide insights into the drug likeness and ability of the constituents to cross blood brain barrier.This research advances our understanding of G. max constituents' therapeutic potential in inhibiting NADPH oxidase, offering valuable insights for herbal medicine applications.The observed interactions highlight a promising avenue for addressing oxidative stress-related conditions, emphasizing the need for further exploration of plant-based remedies in contemporary healthcare.
No takes yet. Share an insight, caveat, or question.
Jaiswal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: